Microplastics (MPs) are pervasive in the environment, posing a significant global environmental challenge. Agricultural ecosystems are particularly vulnerable to MP contamination due to the extensive use of plastics in farming practices. This issue is further aggravated by the application of organic fertilizers, sludge, and wastewater, which introduce additional MPs into the soil. These particles can alter the physiological and biochemical processes of plants, leading to impaired growth. In the current review, we explored the profound effects of MPs on soil health, P dynamics and microbial functionality, and highlighted microbiome-based strategies, including phosphate-solubilizing microbes and innovative remediation approaches, as promising solutions to mitigate MP impacts and restore soil health and agricultural sustainability. A comprehensive literature search was conducted in the Web of Science, Scopus, and ScienceDirect databases for peer-reviewed studies published up to November 2025. Eligible articles were systematically screened and synthesized using a thematic approach to assess the interactions among MPs, phosphorus dynamics, soil microbial communities, and microbial degradation in agricultural soils. As MPs migrate and disperse, they disrupt soil ecosystems and may ultimately threaten human health through their entry into the food chain, making the threat of MPs to agriculture an increasingly critical issue. MPs significantly impact phosphate dynamics by adsorbing phosphates onto their surfaces, reducing bioavailable phosphorus, and interfering with P-related enzymes such as acid phosphatase, alkaline phosphatase, and phytase, which are critical for P mineralization and cycling. Furthermore, MPs disrupt soil microbial communities, affecting phosphate-solubilizing bacteria and fungi, compounding nutrient imbalances, and reducing soil fertility. These disruptions cascade through the agricultural ecosystem, undermining productivity and sustainability.
Safae ER. Raouan, H. Bellouk, Imane Er Raouan et al.· CABI Reviews· 0 citations
Solanum elaeagnifolium has been utilized for its analgesic, anti-inflammatory, and antioxidant properties to treat a range of conditions, including pain and inflammation. It possesses antibacterial, insecticidal, and molluscicidal properties as well. To investigate the pharmacological potential of the S. elaeagnifolium extract, in vitro, in vivo, and in silico studies were used. Albumin denaturation, heat-induced anti-haemolytic action, and lipooxygenase inhibition were the three techniques used to test anti-inflammatory effectiveness. The phenolic chemicals utilized were identified through the use of high-performance liquid chromatography (HPLC). The effectiveness of the extract in lowering problems connected to diabetes was further evaluated by evaluating fructosamines, carbonyl groups, and β-amyloid formations in albumin glycation. Regarding in vivo studies, the Writhing test and the tail flick test were the two techniques used to evaluate analgesic activity. For docking analysis, we used the following identifiers: cyclooxygenase (PDB ID: 6COX), lipooxygenase (PDB ID: 3V99) and VC1 domain of the receptor for advanced glycation products (PDB ID: 7LMW). The most prevalent phenolic chemicals, according to HPLC analysis, were 3,4-dihydroxybenzoic acid (4.78%), caffeic acid (1.28%), gallic acid (8.18%), ursolic acid (2.6%), syringic acid (1.78%), quercetin (24.09%), catechin (6.67%), and p-coumaric acid (20.49%). Significant suppression of albumin glycation and fructosamine production was demonstrated by the extract, indicating that it may help lessen difficulties associated with diabetes. Furthermore, the extract demonstrated a strong anti-inflammatory impact, with an IC50 of 146 ± 1.17 μg/mL for lipooxygenase inhibition, 87.64 ± 5.35 μg/mL for anti-haemolytic action, and 86.94 ± 1.63 μg/mL for albumin denaturation inhibition. A similar analgesic effect to those of analgesic medications was also demonstrated by SEFE extract. Reinforcing the relevance of the observed effects, the in silico study of the tested activities validated these findings. These findings indicate significant pharmacological promise in the management of diabetes consequences, including inflammation and protein glycation, as well as an analgesic.
Mohammed Bouslamti, Rhizlan Abdnim, Rafik El-mernissi et al.· Current Issues in Molecular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
